Leading the new pack of bulls who forecast a big leap in the U.S. economy and the stock market are the economists and analysts at Goldman Sachs. And they’ve a compiled a large batch of their “best-idea” stocks that they’re conv…
Mergers, acquisitions and major restructurings made Big Pharma a much smaller and leaner sector, with some 54,000 jobs lost. At least that’s better than 2009’s 61,000 layoffs.
Continue reading Which Sector Lost…
Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting — if not always positive — year. Here’s our rundown of the…
With interest rates so low and corporations sitting on $2 trillion in cash, a slew of mergers and takeovers across a number of industries appears likely in 2011. But picking individual companies is awfully tough. Here’s a bette…
German pharmaceutical and chemical company Merck KGaA will pay $280 million to settle a U.S. Department of Justice claim brought against a former subsidiary, Dey Pharma, regarding Medicare and Medicaid reimbursements. This is t…